Beactica is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics.
Founded in 2006 based on research carried out at Uppsala University, Beactica has established a robust reputation as a leader in SPR-based drug discovery.
As well as building collaborations with external companies, Beactica is progressing its own drug discovery programmes.
